Patents by Inventor Naomi Esaki

Naomi Esaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND LATANOPROST
    Publication number: 20220387444
    Abstract: An aqueous composition of latanoprost and SAE-CD is provided. The composition possesses improved stability over otherwise similar compositions excluding SAE-CD. Methods of and systems for treating disease, disorders, conditions or symptoms of the eye that are therapeutically responsive to latanoprost are also provided.
    Type: Application
    Filed: August 9, 2022
    Publication date: December 8, 2022
    Inventors: Naomi Esaki, James D. Pipkin
  • Composition containing sulfoalkyl ether cyclodextrin and latanoprost
    Patent number: 11433082
    Abstract: An aqueous composition of latanoprost and SAE-CD is provided. The composition possesses improved stability over otherwise similar compositions excluding SAE-CD. Methods of and systems for treating disease, disorders, conditions or symptoms of the eye that are therapeutically responsive to latanoprost are also provided.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: September 6, 2022
    Assignee: CyDex Pharmaceuticals, Inc.
    Inventors: Naomi Esaki, James D. Pipkin
  • COMPOSITION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND LATANOPROST
    Publication number: 20200179400
    Abstract: An aqueous composition of latanoprost and SAE-CD is provided. The composition possesses improved stability over otherwise similar compositions excluding SAE-CD. Methods of and systems for treating disease, disorders, conditions or symptoms of the eye that are therapeutically responsive to latanoprost are also provided.
    Type: Application
    Filed: November 1, 2019
    Publication date: June 11, 2020
    Inventors: Naomi Esaki, James D. Pipkin
  • Composition containing sulfoalkyl ether cyclodextrin and latanoprost
    Patent number: 10463677
    Abstract: An aqueous composition of latanoprost and SAE-CD is provided. The composition possesses improved stability over otherwise similar compositions excluding SAE-CD. Methods of and systems for treating diseases, disorders, conditions or symptoms of the eye that are therapeutically responsive to latanoprost are also provided.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: November 5, 2019
    Assignee: CyDex Pharmaceuticals, Inc.
    Inventors: Naomi Esaki, James D. Pipkin
  • Composition Containing Sulfoalkyl Ether Cyclodextrin and Latanoprost
    Publication number: 20120021013
    Abstract: An aqueous composition of latanoprost and SAE-CD is provided. The composition possesses improved stability over otherwise similar compositions excluding SAE-CD. Methods of and systems for treating diseases, disorders, conditions or symptoms of the eye that are therapeutically responsive to latanoprost are also provided.
    Type: Application
    Filed: November 7, 2008
    Publication date: January 26, 2012
    Applicant: CyDex Pharmaceuticals, Inc.
    Inventors: Naomi Esaki, James D. Pipkin